iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USA.

Autor:	Saberi P; Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, USA., Stoner MCD; Women's Global Health Imperative, RTI International, Berkeley, California, USA mcstoner@rti.org., McCuistian CL; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA., Balaban C; Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, USA., Ming K; Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, USA., Wagner D; Women's Global Health Imperative, RTI International, Berkeley, California, USA., Chakraborty B; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, NC, USA.; Centre for Quantitative Medicine and Program in Health Services and Systems Research, Duke-NUS Medical School, Singapore.; Department of Statistics and Data Science, National University of Singapore, Singapore., Smith L; Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, USA., Sukhija-Cohen A; AIDS Healthcare Foundation, Los Angeles, California, USA., Neilands TB; Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, USA., Gruber VA; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, CA, USA., Johnson MO; Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California, USA.
Jazyk:	angličtina
Zdroj:	BMJ open [BMJ Open] 2023 Oct 06; Vol. 13 (10), pp. e077676. Date of Electronic Publication: 2023 Oct 06.
DOI:	10.1136/bmjopen-2023-077676
Abstrakt:	Introduction: Young adults with HIV (YWH) experience worse clinical outcomes than adults and have high rates of substance use (SU) and mental illness that impact their engagement in care and adherence to antiretroviral therapy (ART). The intervention for Virologic Suppression in Youth (iVY) aims to address treatment engagement/adherence, mental health (MH) and SU in a tailored manner using a differentiated care approach that is youth friendly. Findings will provide information about the impact of iVY on HIV virological suppression, MH and SU among YWH who are disproportionately impacted by HIV and at elevated risk for poor health outcomes. Methods and Analysis: The iVY study will test the effect of a technology-based intervention with differing levels of resource requirements (ie, financial and personnel time) in a randomised clinical trial with an adaptive treatment strategy among 200 YWH (18-29 years old). The primary outcome is HIV virological suppression measured via dried blood spot. This piloted and protocolised intervention combines: (1) brief weekly sessions with a counsellor via a video-chat platform (video-counselling) to discuss MH, SU, HIV care engagement/adherence and other barriers to care; and (2) a mobile health app to address barriers such as ART forgetfulness, and social isolation. iVY has the potential to address important, distinct and changing barriers to HIV care engagement (eg, MH, SU) to increase virological suppression among YWH at elevated risk for poor health outcomes. Ethics and Dissemination: This study and its protocols have been approved by the University of California, San Francisco Institutional Review Board. Study staff will work with a Youth Advisory Panel to disseminate results to YWH, participants and the academic community. Trial Registration Number: NCT05877729. Competing Interests: Competing interests: None declared. (© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu